SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-16-016223
Filing Date
2016-06-23
Accepted
2016-06-23 16:38:07
Documents
4
Period of Report
2016-06-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1601627_8k.htm 8-K 24906
2 EXHIBIT 1.1 t1601627_ex1-1.htm EX-1.1 248615
3 EXHIBIT 5.1 t1601627_ex5-1.htm EX-5.1 10796
4 GRAPHIC logoex5-1.jpg GRAPHIC 5740
  Complete submission text file 0001571049-16-016223.txt   293672
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 161728996
SIC: 2834 Pharmaceutical Preparations